Covax Australia makes the finalists list

Covax Australia makes the finalists list

Covax Australia have made it to the finalists under category IABCA Excellence in Innovation, which recognises a start-up or business that has exercised innovation in contriving a new and unique business model.

Covax Australia was founded by Mannu Kala and Dr Anuj Gupta in 2020. The idea struck them after they realised most of the clinics and hospitals were unequipped to manage the respiratory illness of the population. This was also the time when there weren’t any adequate access to telehealth and specialist respiratory clinics were fewer in numbers. Moreover, general practitioner clinics started to refuse patients showing symptoms of COVID-19.

Staying away most of the time from media limelight, former MedLab Pathology Queensland general manager Mannu Kala and his co-founder Dr Anuj Gupta were quietly going about their job the results of which were discernible not merely in Queensland, but throughout Australia.

According to Business News Australia report, the highlights of some of their efforts comprise operating specialist respiratory clinics right at the outset of the pandemic, managing drive-thru testing facilities, organising the logistics rollout of the vaccine, and more significantly the recent success in manufacturing PPE.

In all these endeavours Covax Australia stayed away from the limelight, though they were right there in strengthening the nation’s response to the pandemic.

With the pandemic showing no signs of relenting, states and the Federal Government asked them to assist in devising action plans and procedures for operating respiratory clinics, and to establish drive-thru testing sites. The pair wrote a white paper detailing the logistics processes so as to enable rolling out a COVID-19 vaccine and jabbing as many people as possible. This was the only way out of endless lockdowns. From there on, the Covax Australia began their endeavour to bring on Linfox and Qantas (ASX: QAN) to help move the inoculation nationwide, which was a very difficult task to accomplish.

From September 2020 to April 2022, Covax Australia had about 900 active staff working every day in the company. Though at that time the pandemic was not what it was at its peak, the business of Covax Australia has not declined as it now supports close to 100 aged care facilities with staffing solutions in Queensland, New South Wales and Victoria, reports Business News Australia.

Besides, the company also runs a manufacturing facility that produces rapid antigen tests, one of them being currently under consideration with the Therapeutic Goods Administration. About the future, the co-founders visualize the business would continue to evolve.